PPT-Advances in Guiding Treatment Selection for Patients With Cancer

Introduction ctDNA ctDNA Testing in Oncology Tumor Profiling TissueBased Testing and PlasmaBased Testing Possible Role of PlasmaBased Molecular Profiling Testing Challenges of Analyzing ctDNA. Wagholi. , Pune, INDIA. Recognized as . “Center of Excellence” . by . Department of AYUSH, Govt. of India. Supported by . Department of Atomic Energy (DAE), . Government of India. . Integrated Cancer Treatment and Research . First . Line and Beyond. Moderator:. Joseph Gligorov, MD, . PhD . Head, Cancer . Coordination Center . HUEP. University . Cancer . Institute. Sorbonne University. Paris. , . France. Panelist:. Carlos H. Barrios, . Cancer Research Progress. Major Advances in Medical Oncology and Our Path. Forward. Richard L. Schilsky, MD, FACP, FASCO. Senior Vice President and Chief Medical Officer. American Society of Clinical Oncology. Advanced Malignancies. METHODS. DISCUSSION. RESULTS. . ACKNOWLEGEMENTS. . BACKGROUND. Current approaches in the treatment of advanced cancer are based predominantly upon lessons learned from the cytotoxic era. Our current approaches have yielded incremental steps forward, but most patients who develop metastatic disease still die and the costs of care are . Wagholi. , Pune, INDIA. Recognized as . “Center of Excellence” . by . Department of AYUSH, Govt. of India. Supported by . Department of Atomic Energy (DAE), . Government of India. . Integrated Cancer Treatment and Research . Sharon . Manne, PhD. Professor of Medicine. Division of Medical Oncology, Section of Population Science. Rutgers Robert Wood Johnson Medical School. Associate Director, Cancer Prevention, Control, . and Population . Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Practitioner. Abramson . Cancer Center of the University of Pennsylvania. Disclosure of Conflicts of Interest. Beth . Eaby. -Sandy, MSN, CRNP, . O. CN. ®. 1 V Levy2 G Rustin 3 T Perren4 AH Calvert5 H Earl6 and JM Thompson2 1 Royal Marsden NHS Trust London UK 2 Bristol-Myers Squibb London UK 3 Mount Vernon Centre for Cancer Treatment Northwood UK 4/CRF C Sophia . Lamey.  . Background .  . Many advances have been made in recent years in profiling cancers on a more specific cellular or genetic level. These new technologies have led to insights for cancer treatment decisions. . 1 vical Cancer Guidelines: Recommendations for Practice Authors: Nick Reed, Janos Balega, Tara Barwick, Lynn Buckley, Kevin Burton, Gemma Eminowicz, Jenny Forrest, Raji Ganesan, Cath rine Hollan An Educational Slide Set . American Society of Hematology 2020 Guidelines . for Management of Venous Thromboembolism. Slide set author: . Siraj . Mithoowani. MD, MHPE (McMaster University). Clinical Guidelines. What. . about. HCV?. HCV . reactivation. . (. HCVr. ). Definition. Increase. in HCV-RNA . level. of ≥ 1 log. 10 . IU/. mL. from baseline HCVRNA . following. . institution. of . cancer. treatment. 2020-02-25. Hokyun Jeon, Seng Chan You MD, MS, . Rae . Woong. Park MD, PhD. Backgrounds. FOLFOX. FOL. . - . FOLinic. acid (leucovorin). F . . - Fluorouracil (5-FU). OX. . - . OXaliplatin. Malignant Neoplasm. The Role of a Dietitian in Oncology services. Dietitians work across cancer sites and across treatment types.. Work with patients undergoing chemotherapy, radiotherapy and surgical treatment. . Work to combat side effects of cancer and side effects of treatment. .